January 5, 2026 · Form 4 insider transaction
Burik David bought 100,000 shares of NRC HEALTH at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029.